Julian Baker’s Scribe Therapeutics SCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.7M Buy
+688,691
New +$18.2M 0.06% 59

Other funds holding SCTX

Julian Baker's SCTX Position: Q3 2026 in Review

Julian Baker opened a new position in Scribe Therapeutics (SCTX) in Q3 2026: 688,691 shares worth $12.7M. The stake represents 0.06% of the portfolio and ranks #59 among its holdings.

62 funds tracked by Wall St. Rank hold SCTX as of Q3 2026.

  • Julian Baker held 688,691 shares of Scribe Therapeutics worth $12.7M as of Q3 2026.
  • Scribe Therapeutics was a new Julian Baker position in Q3 2026.
  • Scribe Therapeutics made up 0.06% of Julian Baker's portfolio in Q3 2026, its #59 holding.
  • 62 funds tracked by Wall St. Rank held Scribe Therapeutics as of Q3 2026.

Based on Baker Bros. Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.